Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies disclosed economic exposure to Advanced Medical Solutions via 8,240,710 cash-settled derivatives representing 3.72% of 5p ordinary shares with zero direct holdings. It reported an equity-swap transaction increasing a long position by 170,194 referenced at 283.00p per share, held on 11-11-2026 and disclosed on 12-11-2026, and stated no stock-settled derivatives, subscription rights, indemnities or other arrangements.

Disclaimer*

UK 100